EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage

Jonas Österlind iD, Johan Birnefeld, Elin Birnefeld, Magnus Hultin iD, Sara Qvarlander iD, Anders Wåhlin, Petter Holmlund, Laleh Zarrinkoob

PLOS One · 2025

DOI: 10.1371/journal.pone.0338688 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Jonas Österlind und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Anesthesiology and Intensive Care, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Anesthesia, General, Cerebrovascular Circulation, Hypertension, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart–Lung Foundation, Region Västerbotten (ALF funding, Umeå University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Maintaining cerebral perfusion during anesthesia and intensive care is critical, yet the relationship between mean arterial pressure (MAP) and cerebral blood flow (CBF) remains poorly defined. In patients with aneurysmal subarachnoid hemorrhage (aSAH), pharmacologically induced hypertension is commonly applied to support cerebral perfusion, but its effects are uncertain.

Methods

This protocol describes two parallel clinical studies using identical methodology. The first study population includes adults undergoing elective general anesthesia (MAP-ANE), and the second comprises sedated intensive care patients with aSAH (MAP-SAH). In both study populations, MAP will be increased stepwise with norepinephrine (NE) infusion under continuous invasive blood pressure monitoring, and CBF measured with phase-contrast MRI (PCMRI) and arterial spin labeling (ASL), while near-infrared spectroscopy (NIRS) will be performed in parallel to evaluate its validity as a surrogate marker. The primary outcome is the change in total CBF between baseline and elevated MAP, directly testing whether induced hypertension increases CBF. Secondary outcomes include ASL perfusion changes, the slope of the MAP–CBF relationship, systemic–cerebral hemodynamic correlations, and NIRS responses. Expected impact These studies test the hypothesis that pharmacological MAP augmentation does not predictably increase CBF. By combining quantitative MRI with invasive monitoring, it aims to clarify MAP–CBF interactions, define the physiological basis of induced hypertension, and assess whether NIRS can serve as a clinically useful proxy. Findings are expected to inform safer and more individualized blood pressure management in perioperative and neurocritical care. The studies are registered at ClinicalTrials.gov (MAP-ANE: NCT06855407; MAP-SAH: NCT06033378).

Trial registration

ClinicalTrials.gov, MAP-ANE NCT06855407 , MAP-SAH NCT06033378

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anesthesia, GeneralCerebrovascular CirculationHypertensionMagnetic Resonance ImagingSubarachnoid HemorrhageAdultAgedFemaleHumansMaleMiddle AgedBlood PressureIntensive Care UnitsNorepinephrineSpectroscopy, Near-InfraredClinical Trials as Topic

Substanzen

Norepinephrine

Autor:innen und Institutionen

  • Department of Diagnostics and Intervention, Anesthesiology and Intensive Care, Umeå University, Umeå, Sweden.
  • Department of Clinical Sciences, Neurosciences, Umeå University, Umeå, Sweden.
  • Department of Diagnostics and Intervention, Biomedical Engineering and Radiation Physics, Umeå University, Umeå, Sweden.
  • Department of Diagnostics and Intervention, Umeå Centre for Functional Brain Imaging (UFBI), and Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.
  • Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.

ORCID-Profile: Jonas Österlind, Magnus Hultin, Sara Qvarlander

Förderung

  • Swedish Heart–Lung Foundation
  • Region Västerbotten (ALF funding
  • Umeå University
  • Hjärt-Lungfonden
  • Region Västerbotten
  • UmeÃ¥ Universitet

Zitieren

APA

Österlind, J., Birnefeld, J., Birnefeld, E., Hultin, M., Qvarlander, S., Wåhlin, A., Holmlund, P., & Zarrinkoob, L. (2025). Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage. PLOS One. https://doi.org/10.1371/journal.pone.0338688

Vancouver

Österlind J, Birnefeld J, Birnefeld E, Hultin M, Qvarlander S, Wåhlin A, et al. Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage. PLOS One. 2025. doi:10.1371/journal.pone.0338688

BibTeX
@article{sterlind2025,
  author = {Österlind, Jonas and Birnefeld, Johan and Birnefeld, Elin and Hultin, Magnus and Qvarlander, Sara and Wåhlin, Anders and Holmlund, Petter and Zarrinkoob, Laleh},
  title = {Study protocol: MRI-based assessment of cerebral blood flow under pharmacologically elevated blood pressure in patients under general anesthesia, and in sedated ICU patients with aneurysmal subarachnoid hemorrhage},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338688}
}
Kostenlos starten →